Joshi Manher insider trades
Joshi Manher has filed 6 Form 4s with the SEC that we hold, for SLNO (Chief Development Officer), Atara Biotherapeutics, Inc. (ATRA) (EVP, Chief Medical Officer) and Rhythm Pharmaceuticals, INC. (RYTM) (Chief Medical Officer). Across all of them we count 0 purchases worth $0 and 3 sales worth $16.3K reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 3,773 shares of Atara Biotherapeutics, Inc. worth $6.2K, dated 2023-08-16. The first filing on our record is dated 2023-08-18 and the latest 2026-08-18.
SLNO
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Atara Biotherapeutics, Inc. (ATRA)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2023-08-16 | S, sale reported on Form 4 | 3,202 | $5.3K | 2023-08-18 |
| 2023-08-16 | S, sale reported on Form 4 | 3,773 | $6.2K | 2023-08-18 |
| 2023-11-16 | S, sale reported on Form 4 | 12,287 | $4.8K | 2023-11-20 |
Rhythm Pharmaceuticals, INC. (RYTM)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1978048) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms